[Seite 91↓]


Ahnhudt C, Muche M, et al.: An approach to the sensitivity of temperaturgradient gel electrophoresis in the detection of clonally expanded T-cells in cutaneous T-cell lymphoma. Electrophoresis 2001; 22 :33-38

Bernengo M, Quaglino P, et al.: Prognostic factors in Sézary syndrome: A multivariate analysis of clinical, haematological and immunological features. Annals of Oncology 1998;9 :857-863

Bernengo M, Novelli M, et al.: The relevance of the CD4+CD26- subset in the identification of circulating Sézary cells. Br J Dermatol 2001 ;144 :125-135

Bigler R, Boselli C, et al.: Failure of anti-T-cell receptor V beta antibodies to consistently identify a malignant T-cell clone in Sezary syndrome. Am J Pathol 1996 ;149:1477-1483

Breit T, Wolvers-Tettero I, et al.: Receptor diversity of human T-cell receptor γ δ expressing cells. Progress in Histo- and Cytochemistry 1992 ;26:182-193

Breslauer K, Frank R, et al.: Predicting DNA duplex stability from the base sequence. Proceedings of the National Academy of Science of the USA 1986;83: 3746-3750

Bogen S, Pelley D, et al.: Immunophenotypic Identification of Sezary Cells in the Peripheral Blood. Am J Clin Pathol 1996 ;106 :739-748

Bsnier E, Hallopeau: On the erythrodermia of Mycosis fungoides. J Cutan Genitouri Disease 1892;10:453

Buechner S, Winkelmann R: Sézary Syndrome: A clinicopathologic Study of 39 Cases. Arch Dermatol 1983;119:979-986

Burg G, Dummer R, et al.: Classification of Cutaneous Lymphomas. Dermatologic Clinics 1994 ;12 (2): 213-217

Chan A, Reynolds P, et al.: Tyrosine kinase activity associated with the CD7 antigen: correlation with regulation of T cell integrin function. Eur J Immunol 1994;24:2602-2608

Chan D, Liang R, et al.: Detection of T-Cell Receptor Delta Gene Rearrangement in T-Cell Maligancies by Clonal Specific Polymerase Chain Reaction and its Application to detect minimal residual Disease . American Journal of Hematology 1996 ; 52 : 171-177

Dongen J, Comans-Bitter M, et al.: Development of human T lymphocytes and their thymus-dependency. Thymus 1990;16 (3-4):207-234

Dummer R, Haeffner A, et al.: Cutaneous T-Cell lymphomas (CTCL): new aspects in PCR-based diagnostic tools, immunology and treatment. Eur J Dermatol 1994;4 (4): 281-286

Dummer R, Nestle F, et al.: Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sézary syndrome. Arch Dermatol Res 1999;291:307-311

Dummer R, Nestle F, et al.: Pathogenesis of Cutaneous Lymphomas. Semin Cutan Med Surg 2000;19:78-86

Dummer R, Willers J, et al.: Aktuelle Aspekte zur Pathogenese von Sézary-Syndrom und Mycosis fungoides. Hautarzt 2001;52: 189-192

Eckert C, Landt O, et al.: Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia: Leukemia 2000;14(2):316-23

Edelson R, Lutzner M: Morphologic and functional properties of the atypical T-Lymphocytes of Sézary Syndrome. Mayo Clin Proc 1974;49: 558-66

Edelson R: Cutaneous T cell lymphoma: Mycosis fungoides, Sézary syndrome, and other variants. J Am Acad Dermatol 1980;2(2): 89-106

[Seite innerhalb Literaturhinweis 92↓]

Fink-Pouches R., Zenahlik P., et al.: Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. Blood 2002;99(3): 800-805

Forster A, Huck S, et al.: New subgroups in the human T-cell rearranging V(gamma) gene locus. EMBO 1987;6: 1945 -50

Fraser-Andrews E, Russel-Jones R, et al.: Diagnostic and Prognostic Importance of T-Cell Receptor Gene Analysis in Patients with Sézary Syndrome. Cancer 2001;92:1745-1752

Fritsch: “Dermatologie und Venerologie”-Lehrbuch und Atlas, Springer 1998;634-639

Ginaldi L, Farahat N, et al.: Differential expression of T cell antigens in normal peripheral blood lymphocytes: a quantitative analysis by flow cytometrie. J Clin Pathol 1996;49:539-544

Ginés S, Marino M, et al.: Regulation of epithelial and lymphocyte cell adhesion by adenosine deaminase-CD26 interaction. Biochem J 2002;361:203-209

Gorrell M, Gysbers V, et al.: CD26: A Multifunctional Integral Membrane and Secretes Protein of Activated Lymphocytes. Scand J Immunol 2001;54:249-264

Gutzmer R, Mommert S, et al.: Detection of Clonal T Cell Receptor γ Gene Rearrangements in Cutaneous T Cell Lymphoma by LightCycler-Polymerase Chain Reaction. J Invest Dermatol 2001;116:926-932

Harris N., Jaffe E., et al.: A Revised European-American Classification of Lymphoid Neoplasms: A Proposal From the International Lymphoma Study Group. Blood 1994;84(5): 1361-1392

Harmon C, Witzig T, et al.: Detection of circulating T cells with CD4+CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol 1996;35:404-410

Haynes B, Bunn P, et al.: Cell surface Differentiation Antigens of the Malignant T Cell in Sezary Syndrome and Mycosis Fungoides . J Clin Invest 1981; 67:523-530

Hildebrandt M, Reutter W, et al.: A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition an immune defence. Clin Science 2000;99:93-104

Isaacson P, Norton A: “Extranodal LymphomaChurchill Livingstone 1994; 172

Jaffe E, Harris N, et al.: World Health Organization Classification of neoplastic diseases of the hematopoietic and lymphoid tissues . Am J Clin Pathol 1999;S8-S12

Jakob T, Neuber K, et al.: Stage-dependent Expression of CD7, CD45RO, CD45RA and CD25 on CD4-positive Peripheral Blood T-Lymphocytes in Cutaneous T-cell Lymphoma. Acta Derm Venereol 1996;76:34-36

Johnson G, Dewald G, et al.: Chromosome studies in 17 patients with the Sezary syndrome. Cancer 1985;55(10):2426-2433

Jones D, Dang N, et al.: Absence of CD26 Expression Is a Useful Marker for Diagnosis of T-Cell Lymphoma in peripheral Blood. Am J Clin Pathol 2001;115:885-892

Jung R, Soondrum K, et al.: Quantitative PCR. Clin Chem Lab Med 2000; 38(9):833-836

Kneba M, Bolz I, et al.: Characterization of Clone-Specific Rearranged T-Cell Receptor γ -Chain Genes in Lymphomas and Leukemias by the Polymerase Chain Reaction and DNA Sequencing. Blood 1994;84(2):574-581

Kneba M, Bolz I, et al.: Analysis of rearranged t cell receptor β -chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR Fragment Analysis. Blood 1995;96: 3930-37

Kukel S, Reinhold U, et al.: Progressive increase of CD7- T cells in human blood lymphocytes with ageing. Clin Exp Immunol 1994;98:163-168

Laetsch B, Haeffner A, et al.: CD4+/CD7- T Cell Frequency and Polymerase Chain Reaction-Based Clonality Assay Correlate with Stage in Cutaneous T Cell Lymphoma. J Inv Dermatol 2000;14(1):107-111

[Seite innerhalb Literaturhinweis 93↓]

Lazarovits A, Osman N, et al.: CD7 is Associated with CD3 and CD45 on Human T Cells. J Immunol 1994;153:3956-3966

Lee B, Duvic M, et al.: Dysregulated Synthesis of Intracellular Type 1 and Type 2 Cytokines by T Cells of Patients with Cutaneous T Cell Lymphoma. Clin Diag Lab Immunol 1999;6(1):79-84

Lefranc M, Chuchana P, et al.: Molecular mapping of the human T-cell receptor gamma (TRG) genes and linkage of the variable and constant regions. Eur J Immunol 1989;19: 989-94

Lessin S, Rook A, et al.: Molecular Diagnosis of Cutaneous T-Cell Lymphoma: Polymerase Chain Reaction Amplification of T-Cell Antigen Receptor β -Chain Gene Rearrangements. J Invest Dermatol 1991;91:299-302

Liu L, Abken H, et al.: Accumulation of CD4+CD7- T cells in inflammatory skin lesions: evidence for preferential adhesion to vascular endothelial cells. Clin Exp Immunol 2000;121:94-99

Lukowsky A, Audring H, et al.: Nachweis von monoklonalen T-Zellen mittels TCR γ -PCR bei Mycosis Fungoides(MF). Hautarzt 1998;49:641-645

Lukowsky A, Muche M, et al.: Detection of expanded T Cell Clones in Skin Biopsy Samples of Patients with Lichen Sclerosus et atrophicus by T Cell Receptor- γ Polymerase Chain Reaction Assays . J Invest Dermatol 2000;115(2):254-259

Lutzner M, Jordan H: The ultrastructure of an abnormal cell in Sézary Syndrom. Blood 1968;31:719-726

Meyer C, Leeuwen A, et al.: Cerebriform (Sezary Like) Mononuclear Cells in Healthy Individuals: A Morphologically Distinct Population of T Cells. Virchows Arch B Cell Path 1977;25:95-104

Meyer J, Hassam S, et al.: A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol 1997;6(3):122-127

Mielke V, Staib G, et al.: Clonal disease in early cutaneous T-cell lymphoma. Dermatol Clin 1994;12:351-360

Moss P, Charmley P, et al.: The Repertoire of T Cell Antigen Receptor β -Chain Variable Regions Associated with Psoriasis Vulgaris. J Invest Dermatol 1997;109(1):14-19

Muche M : PCR- und Elektrophoresetechniken zum Nachweis einer monoklonalen T-Zell-Vermehrung am Beispiel der Diagnostik der Mycosis fungoides. Dissertation 1995.

Muche M, Lukowsky A, et al.: Demonstration of Frequent Occurrence of Clonal T-Cells in the Peripheral Blood of Patients With Primary Cutaneous T-Cell Lymphoma. Blood 1997;90(4):1636-1642

Muche M, Lukowsky A, et al.: Demonstration of frequent occurrence of clonal T cells in the peripheral blood but not in the skin of patients with small plaque parapsoriasis. Blood. 1999;94(4):1409-1417

Muche M, Gellrich S, et al.: Treatment of Cutaneous T-Cell Lymphomas. Sem Cut Med Surg 2000; 19(2):142-148

NCBI-Database: http:///www.ncbi.nlm.nih.gov/blast

Novelli M, Quaglino P, et al.: CD4+CD26- Evaluation is a more useful Diagnostic Parameter than CD4+CD7- in Sezary Syndrome(SS). J Invest Dermatol 1995;105(3):515

Ostendorf P, Seeber S: Hämatologie Onkologie. Urban & Schwarzenberg 1997;33-38

Pace K, Hahn H, et al.: Cutting Edge: CD7 Delivers a Pro-Apoptotic Signal During Galectin-1-Induced T Cell Death. J Immunol 2000;165:2331-2334

Pfitzner T, Reiser M, et al.: Quantitative molecular monitoring of residual tumor cells in chronic lymphocytic leukemia. Ann Hematol 2002;81(5):258-266

Powell E, Kroon P, et al.: Measurement of mRNA by quantitative PCR with nonradioactive label. J Lipid Res 1992; 33: 609-14

Rappl G, Muche M, et al.: CD4+CD7- T cells compose the dominant T-cell clone in the peripheral blood of patients with Sézary syndrome. J Am Acad Dermatol 2001;44(3):456-461

Rappl G, Abken H, et al.: CD4+CD7- leukemic T cells from patients with Sézary syndrome are protected from galectin-1-triggered T cell death. Leukemia 2002;16:840-845

[Seite innerhalb Literaturhinweis 94↓]

Rasmussen R.: Quantification on the LightCycler. in Meuer S, et al.: Rapid cycle real-time PCR, Springer, Heidelberg 2001: 21-35

Reischl U, Kochanowski B: Quantitative PCR. Molecular Biotechnology 1995;3: 55-71

Reinhold U, Abken H, et al.: CD7- T Cells Represent a subset of Normal Human Blood Lymphocytes. J Immunol 1993;150(5):2081-2089

Reinhold U, Liu L, et al.: CD7-negative T cells represent a seperate differention pathway in a subset of post-thymic helper T cells . Immunology 1996;89:391-396

Roche Molecular Biochemicals (a) : Li ght-Cycler-System. Real-time PCR- as flexible as you are. 2000; 12-14

Roche Molecular Biochemicals : Overview of Lightcycler quantification methods, Technical Note LC 2000; 10:11

Rowen L, Koop B, et al.: The complete 685-kilobase DNA sequence of the human beta cell receptor locus. Science 1996; 272:1755-1762

Russel-Jones R, Whittaker S: T-cell receptor gene analysis in the diagnosis of Sézary Syndrome . J Am Acad Dermatol 1999;41(2):254-258

Russel-Jones R, Whittaker S: Sézary Syndrome: Diagnostic Criteria and therapeutic Options. Sem Cut Med Surg 2000;19(2):100-108

Sarris A, Jiang Y, et al.: Quantitative Real-Time Polymerase Chain Reaction for Monitoring Minimal Residual Disease in Patients With Advanced Indolent Lymphomas Treated with Rituximab, Fludarabine, Mitoxantrone, and Dexamethasone. Semin Oncol 2002;29(2):48-55

Scala E, Russo G, et al.: Skewed Expression of Activation, Differentiation and Homing-Related Antigens in Circulating Cells from Patients with Cutaneous T Cell Lymphoma Associated with CD7- T Helper Lymphocytes Expansion. J Invest Dermatol 1999;113:622-627

Scarisbrick J, Whittacker S, et al.: Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma. Blood 2001;97 (3):624-629

Scarisbrick J, Woolford A, et al.: Allelotyping in Mycosis Fungoides and Sezary Syndrome: Common Regions of Allelic Loss Identified on 9p, 10q, and 17p. J Invest Dermatol 2001;117(3):663-670

Scarisbrick J, Woolford A, et al.: Frequent Abnormalities of the P15 and P16 Genes in Mycosis Fungoides and Sezary Syndrome. J Invest Dermatol 2002;118(3): 493-499

Schwab C, Willers J, et al.: The use of anti-T-cell receptor-V β antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol 2002; 118:1019-1026

Sézary A, Bouvrain Y: Erythrodermie avee presence de cellules monstreuses dans le derme et dans le sang circulant. Bull Soc Fr Dermatol Syph 1938;45:254-260

Sempowski G, Lee D, et al.: Structure and Function of the CD7 Molecule. Crit Rev Immunol 1999;19:331-348

Sharp J, Chan W: Detection and relevance of minimal disease in lymphomas. Cancer Metastasis Rev 1999;18(1): 127-142

Sterry W, Mielke V, et al.: CD4+ Cutaneous T-Cell Lymphomas Show the Phenotype of Helper/Inducer T Cells (CD45RA-, CDw29+). J Invest Dermatol 1989;93:412-416

Taswell H, Winkelmann R: Sézary Syndrome - a malignant reticulemic erythroderma. JAMA 1961;117:465-472

Trainor K.J., Brisco M.J., et al.: Gene Rearrangement in B- and T- Lymphoproliferative Desease Detected by the Polymerase Chain Reaction. Blood 1991;78(1):192-196

Veelken H, Wood G, et al.: Molecular Staging of Cutaneous T-Cell Lymphoma: Evidence for Systemic Involvement in Early Disease . J Invest Dermatol 1995;104:889-894

Verstovsek S, Cabanillas F, et al.: CD26 in T-Cell Lymphomas: A Potential Clinical Role?. Oncology 2000;14(6):17-23

[Seite innerhalb Literaturhinweis 95↓]

Volkenandt M, Soyer H, et al.: Development of a Highly Specific and Sensitive Molecular Probe for Detection of Cutaneous Lymphoma. J Invest Dermatol 1991;97 :137-140

Volkenandt M, Soyer H, et al.: Molecular detection of clone-specific DNA in hypopigmented lesions of a patient with early evolving mycosis fungoides. Br J Dermatol 1993;128:423-428

Vonderheid E, Bigler R, et al.: Variable CD7 Expression on T Cells in the Leukemic Phase of Cutaneous T Cell Lymphoma (Sezary Syndrome). J Invest Dermatol 2001;117(3): 654-662

Vonderheid E, Bernengo G, et al.: Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95-106

Weinberg J, Jaworsky C, et al.: The Clonal Nature of Circulating Sezary Cells. Blood 1995;86(11):4257-4262

Wetmur J. : DNA probes: applications of the principles of nucleic acid hybridization. Critical Revue in Biochemistry and Molecular Biology 1991;26: 227-259

Whittaker S, Smith N, et al.: Analysis of β , γ and δ T-Cell Receptor Genes in Mycosis Fungoides and Sezary Syndrome. Cancer 1991;68:1572-1582

Whittaker S: Molecular Genetics of Cutaneous Lymphomas. Ann N Y Acad Sci 2001;941: 39-45

Wieselthier J, Koh H et al.: Sézary Syndrome: Diagnosis, prognosis, and critical review of treatment options. J Am Acad Dermatol 1990;22(3):381-401

Willemze R., Kerl H., et al.: EORTC Classification for Primary Cutaneous Lymphomas: A Proposal From the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90(1):354-371

Willemze R., Meijer C.: EORTC Classification for Primary Cutaneous Lymphomas: The Best Guide to Good Clinical Management. The Am J Dermatopathol. 1999;21(3): 265-273

Wood G, Hong S, et al.: Leu-8/CD7 antigen expression by CD3+ T cells: Comparative analysis of skin and blood in mycosis fungoides/Sézary syndrome relative to normal blood values. J Am Acad Dermatol 1990;22:602-607

Wood G, Haeffner A, et al.: Molecular Biology Techniques for the diagnosis of cutaneous T-Cell Lymphoma. Dermatologic Clinics 1994;12(2):231-241

Zelickson B, Peters M, et al.: T-cell receptor gene rearrangement analysis: Cutaneous T cell lymphoma, peripheral T cell lymphoma, and premalignant and benign cutaneous lymphoproliferative disorders. J Am Acad Dermatol 1991;25:787-796

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: